Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk

Monica Marabelli, Su Chun Cheng, Giovanni Parmigiani

Research output: Contribution to journalArticle

Abstract

The gene responsible for ataxia-telangiectasia syndrome, ATM, is also an intermediate-risk breast cancer (BC) susceptibility gene. Numerous studies have been carried out to determine the contribution of ATM gene mutations to BC risk. Epidemiological cohorts, segregation analyses, and case-control studies reported BC risk in different forms, including penetrance, relative risk, standardized incidence ratio, and odds ratio. Because the reported estimates vary both qualitatively and quantitatively, we developed a general model allowing the integration of the different types of cancer risk available in the literature. We performed a comprehensive meta-analysis identifying 19 studies, and used our model to obtain a consensus estimate of BC penetrance. We estimated the cumulative risk of BC in heterozygous ATM mutation carriers to be 6.02% by 50 years of age (95% credible interval: 4.58-7.42%) and 32.83% by 80 years of age (95% credible interval: 24.55-40.43%). An accurate assessment of cancer penetrance is crucial to help mutation carriers make medical and lifestyle decisions that can reduce their chances of developing the disease.

Original languageEnglish (US)
JournalGenetic Epidemiology
DOIs
StateAccepted/In press - 2016
Externally publishedYes

Fingerprint

Penetrance
Meta-Analysis
Breast Neoplasms
Mutation
Genes
Ataxia Telangiectasia
Neoplasm Genes
Case-Control Studies
Life Style
Neoplasms
Consensus
Cohort Studies
Odds Ratio
Incidence

Keywords

  • Ataxia-telangiectasia mutated (ATM) gene
  • Genetic predisposition
  • Hereditary breast cancer
  • Penetrance

ASJC Scopus subject areas

  • Genetics(clinical)
  • Epidemiology

Cite this

Penetrance of ATM Gene Mutations in Breast Cancer : A Meta-Analysis of Different Measures of Risk. / Marabelli, Monica; Cheng, Su Chun; Parmigiani, Giovanni.

In: Genetic Epidemiology, 2016.

Research output: Contribution to journalArticle

@article{63088153e08b499ebc5b459382df45ef,
title = "Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk",
abstract = "The gene responsible for ataxia-telangiectasia syndrome, ATM, is also an intermediate-risk breast cancer (BC) susceptibility gene. Numerous studies have been carried out to determine the contribution of ATM gene mutations to BC risk. Epidemiological cohorts, segregation analyses, and case-control studies reported BC risk in different forms, including penetrance, relative risk, standardized incidence ratio, and odds ratio. Because the reported estimates vary both qualitatively and quantitatively, we developed a general model allowing the integration of the different types of cancer risk available in the literature. We performed a comprehensive meta-analysis identifying 19 studies, and used our model to obtain a consensus estimate of BC penetrance. We estimated the cumulative risk of BC in heterozygous ATM mutation carriers to be 6.02{\%} by 50 years of age (95{\%} credible interval: 4.58-7.42{\%}) and 32.83{\%} by 80 years of age (95{\%} credible interval: 24.55-40.43{\%}). An accurate assessment of cancer penetrance is crucial to help mutation carriers make medical and lifestyle decisions that can reduce their chances of developing the disease.",
keywords = "Ataxia-telangiectasia mutated (ATM) gene, Genetic predisposition, Hereditary breast cancer, Penetrance",
author = "Monica Marabelli and Cheng, {Su Chun} and Giovanni Parmigiani",
year = "2016",
doi = "10.1002/gepi.21971",
language = "English (US)",
journal = "Genetic Epidemiology",
issn = "0741-0395",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Penetrance of ATM Gene Mutations in Breast Cancer

T2 - A Meta-Analysis of Different Measures of Risk

AU - Marabelli, Monica

AU - Cheng, Su Chun

AU - Parmigiani, Giovanni

PY - 2016

Y1 - 2016

N2 - The gene responsible for ataxia-telangiectasia syndrome, ATM, is also an intermediate-risk breast cancer (BC) susceptibility gene. Numerous studies have been carried out to determine the contribution of ATM gene mutations to BC risk. Epidemiological cohorts, segregation analyses, and case-control studies reported BC risk in different forms, including penetrance, relative risk, standardized incidence ratio, and odds ratio. Because the reported estimates vary both qualitatively and quantitatively, we developed a general model allowing the integration of the different types of cancer risk available in the literature. We performed a comprehensive meta-analysis identifying 19 studies, and used our model to obtain a consensus estimate of BC penetrance. We estimated the cumulative risk of BC in heterozygous ATM mutation carriers to be 6.02% by 50 years of age (95% credible interval: 4.58-7.42%) and 32.83% by 80 years of age (95% credible interval: 24.55-40.43%). An accurate assessment of cancer penetrance is crucial to help mutation carriers make medical and lifestyle decisions that can reduce their chances of developing the disease.

AB - The gene responsible for ataxia-telangiectasia syndrome, ATM, is also an intermediate-risk breast cancer (BC) susceptibility gene. Numerous studies have been carried out to determine the contribution of ATM gene mutations to BC risk. Epidemiological cohorts, segregation analyses, and case-control studies reported BC risk in different forms, including penetrance, relative risk, standardized incidence ratio, and odds ratio. Because the reported estimates vary both qualitatively and quantitatively, we developed a general model allowing the integration of the different types of cancer risk available in the literature. We performed a comprehensive meta-analysis identifying 19 studies, and used our model to obtain a consensus estimate of BC penetrance. We estimated the cumulative risk of BC in heterozygous ATM mutation carriers to be 6.02% by 50 years of age (95% credible interval: 4.58-7.42%) and 32.83% by 80 years of age (95% credible interval: 24.55-40.43%). An accurate assessment of cancer penetrance is crucial to help mutation carriers make medical and lifestyle decisions that can reduce their chances of developing the disease.

KW - Ataxia-telangiectasia mutated (ATM) gene

KW - Genetic predisposition

KW - Hereditary breast cancer

KW - Penetrance

UR - http://www.scopus.com/inward/record.url?scp=84964620308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964620308&partnerID=8YFLogxK

U2 - 10.1002/gepi.21971

DO - 10.1002/gepi.21971

M3 - Article

AN - SCOPUS:84964620308

JO - Genetic Epidemiology

JF - Genetic Epidemiology

SN - 0741-0395

ER -